Characterizing Mortality Associated with Idiopathic Multicentric Castleman Disease

被引：4
|
作者：
Pierson, Sheila K. [1 ]
Kanhai, Karan [2 ]
Bagg, Adam [3 ]
Alapat, Daisy [4 ]
Lim, Megan S. [5 ]
Lechowicz, Mary Jo [6 ]
Srkalovic, Gordan [7 ]
Uldrick, Thomas S. [8 ]
van Rhee, Frits [9 ]
Fajgenbaum, David C. [1 ]
机构：
[1] Univ Pennsylvania, Ctr Cytokine Storm Treatment & Lab, Perelman Sch Med, Philadelphia, PA USA
[2] EUSA Pharma, Hemel Hempstead, England
[3] Hosp Univ Pennsylvania, Dept Pathol & Lab Med, Philadelphia, PA USA
[4] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR USA
[5] Univ Pennsylvania, Dept Pathol & Lab Med, Philadelphia, PA USA
[6] Emory Univ, Hematol Med Oncol, Sch Med, Atlanta, GA USA
[7] Sparrow Herbert Herman Canc Ctr, Lansing, MI USA
[8] Fred Hutchinson Canc Res Ctr, Seattle, WA USA
[9] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Div Hematol Oncol, Myeloma Ctr, Little Rock, AR USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-153397
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1623
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Increased Comorbidities and Hospitalizations Associated with Idiopathic Multicentric Castleman Disease
    Bustamante, Mateo Sarmiento
    Pierson, Sheila K.
    Ren, Yue
    Alapat, Daisy
    Bagg, Adam
    Brandstadter, Joshua D.
    Lechowicz, Mary Jo
    Lee, Hongzhe
    Srkalovic, Gordan
    Lim, Megan S.
    van Rhee, Frits
    Fajgenbaum, David C.
    BLOOD, 2022, 140 : 6520 - 6521
  • [2] Multicentric Castleman's Disease, Associated with Idiopathic Thrombocytopenic Purpura
    Sood, Ruchi
    Taylor, Harris C.
    Daw, Hamed
    CASE REPORTS IN HEMATOLOGY, 2013, 2013
  • [3] Idiopathic multicentric Castleman's disease
    Vasilyev, V., I
    Palshina, S. G.
    Pavlovskaya, A., I
    Kokosadze, N., V
    Chaltsev, B. D.
    Shornikova, L. A.
    TERAPEVTICHESKII ARKHIV, 2020, 92 (05): : 78 - +
  • [4] Dissecting idiopathic multicentric Castleman's disease
    Dupin, Nicolas
    LANCET HAEMATOLOGY, 2016, 3 (04): : E153 - E154
  • [5] Polynesian Variant Of Idiopathic Multicentric Castleman Disease
    Zhai, Shaun
    Simpson, David
    BLOOD, 2013, 122 (21)
  • [6] Idiopathic multicentric Castleman disease of TAFRO subtype
    Godfrey, Katherine
    Harris, Emma
    Moss, Hilary
    Martin-Cabrera, Pedro
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (03) : 461 - 461
  • [7] Candidate biomarkers for idiopathic multicentric Castleman disease
    Sumiyoshi, Remi
    Koga, Tomohiro
    Kawakami, Atsushi
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2022, 62 (02) : 85 - 90
  • [8] PrednisoloneRebound effect of idiopathic multicentric castleman disease
    Reactions Weekly, 2024, 2005 (1) : 699 - 699
  • [9] Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomes
    Pierson, Sheila K.
    Lim, Megan S.
    Srkalovic, Gordan
    Brandstadter, Joshua D.
    Bustamante, Mateo Sarmiento
    Shyamsundar, Saishravan
    Mango, Natalie
    Lavery, Criswell
    Austin, Bridget
    Alapat, Daisy
    Lechowicz, Mary Jo
    Bagg, Adam
    Li, Hongzhe
    Casper, Corey
    van Rhee, Frits
    Fajgenbaum, David C.
    BLOOD ADVANCES, 2023, 7 (21) : 6652 - 6664
  • [10] Identification of Autoantibodies Associated with Connective Tissue Disorders in Idiopathic Multicentric Castleman Disease
    Feng, Allan
    Gonzalez, Michael V.
    Mumau, Melanie
    Shyamsundar, Saishravan
    Utz, Paul J.
    Fajgenbaum, David C.
    BLOOD, 2023, 142
12345